Compugen Ltd. (NASDAQ: CGEN) Stock Information | RedChip

Compugen Ltd. (NASDAQ: CGEN)


$1.5200
-0.0100 ( 0% ) 244.7K

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Market Data


Open


$1.5200

Previous close


$1.5300

Volume


244.7K

Market cap


$136.99M

Day range


$1.4800 - $1.6000

52 week range


$1.3500 - $3.0301

SEC Filings


Form Type Description Pages Date
20-f Annual reports 81 Mar 05, 2024
6-k Form 6-K 3 Mar 05, 2024
6-k Form 6-K 3 Feb 15, 2024
6-k Form 6-K 4 Jan 08, 2024
6-k Form 6-K 6 Dec 19, 2023

Latest News